Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
American Airlines enters its October 21 earnings report with short positions entrenched near a month-long peak and the analyst community still cutting targets, a week after the picture was already looking charged.
Short interest has remained elevated since the previous note, now at 13.7% of the free float, representing around 90.7 million shares. That is roughly flat with where it finished last week, but the month-on-month build of 25% tells the longer story: bears have added meaningfully over October and have not retreated into earnings week. A single-day jump of 9.5% on October 13 extended the position after a brief mid-week dip, suggesting the re-entry was deliberate rather than accidental. The ORTEX short score has eased slightly from its early-October peak of 51.4 to 50.2, still close to neutral, which means the build reflects conviction rather than a scoring extreme. Despite the heavy position, the lending market remains loose. Availability is at 576%, down from 635% a week ago but still indicating no shortage of shares to borrow. Borrowing costs are 0.43%, barely changed on the week. This is not a setup primed for a squeeze.
Options traders lean cautious but not aggressively so. The put/call ratio at 1.51 is slightly above its 20-day average of 1.47, and the z-score of 0.63 places it well within normal range. For context, the 52-week high on the PCR is 2.41, so current options skew reflects mild defensiveness rather than panic buying of puts. The options picture and the short interest picture are telling the same story: deliberate caution, not an extreme bet either way.
The Street is firmly in target-cutting mode, and the direction of travel has not shifted since last week. Goldman Sachs holds a Sell rating with a target of $11, below the current price of $12.50. Susquehanna trimmed to $15 from $20 as recently as October 7. Wells Fargo cut to $14 from $17 on October 6. Of the names that retain Buy ratings, TD Cowen and UBS both reduced their targets this month. The mean analyst target at $15.93 implies around 27% upside from current levels, but the consensus is built on a split house: the bears are at $11 and the bulls at $17, with most of the recent action pointing downward. The PE multiple has expanded over the past month as the stock has fallen on flat earnings estimates, now at 13.7 times. EV/EBITDA is running at 7.3 times, up about one full turn over 30 days. Neither looks stretched for an airline, but the trend in earnings-estimate momentum is firmly negative: the 30-day EPS momentum factor scores in just the 1st percentile, and the 90-day reading is in the 5th.
One signal worth noting is a spike in retail and market attention. Wikipedia and ORTEX page-view data show AAL's attention score running at a z-score of 2.8 versus its own 90-day history, the highest reading in the alt data set. That kind of attention often precedes a volatile event rather than a directional move, which fits the earnings-week context. Separately, BTS passenger data shows T-100 passengers carried rising for three consecutive months through July, a positive traffic read, but no measured lead to AAL's reported financials has been established from that data, so it is colour rather than signal.
Within the peer group, AAL is not alone in its weakness. UAL fell 7.7% on the week and JBLU dropped 16.9%, the worst of the group. DAL and ALK lost closer to 5%. The sector is broadly soft, but AAL's short interest is running well above peers, making it the more leveraged expression of airline-sector pessimism. PRIMECAP, the largest institutional holder with a 10.7% stake, added 21.7 million shares as recently as July, a significant accumulation that sits as the counterweight to the bear camp.
The Q3 print on October 21 is the next decision point: watch whether short interest continues to build or covers into the release, and whether analyst targets stabilise or the cutting cycle extends.
See the live data behind this article on ORTEX.
Open AAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
